CDK4 and glioma: To further demonstrate the regulatory role of cyclin D1 in the glia-fate induction of glioma cells, we introduced a functional pharmacologic inhibitor of CDK4 and 6 which bind to cyclin D1 to form a complex required for G1-S cell cycle phase progression [15].